Your browser doesn't support javascript.
loading
Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019.
Tenforde, Mark W; Cummings, Charisse N; O'Halloran, Alissa C; Rothrock, Gretchen; Kirley, Pam Daily; Alden, Nisha B; Meek, James; Yousey-Hindes, Kimberly; Openo, Kyle P; Anderson, Evan J; Monroe, Maya L; Kim, Sue; Nunez, Val Tellez; McMahon, Melissa; McMullen, Chelsea; Khanlian, Sarah A; Spina, Nancy L; Muse, Alison; Gaitán, Maria A; Felsen, Christina B; Lung, Krista; Shiltz, Eli; Sutton, Melissa; Thomas, Ann; Talbot, H Keipp; Schaffner, William; Price, Andrea; Chatelain, Ryan; Reed, Carrie; Garg, Shikha.
Afiliación
  • Tenforde MW; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Cummings CN; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • O'Halloran AC; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Rothrock G; California Emerging Infections Program, Oakland, California, USA.
  • Kirley PD; California Emerging Infections Program, Oakland, California, USA.
  • Alden NB; Colorado Department of Public Health and Environment, Denver, Colorado, USA.
  • Meek J; Connecticut Emerging Infections Program, New Haven, Connecticut, USA.
  • Yousey-Hindes K; Yale School of Public Health, New Haven, Connecticut, USA.
  • Openo KP; Connecticut Emerging Infections Program, New Haven, Connecticut, USA.
  • Anderson EJ; Yale School of Public Health, New Haven, Connecticut, USA.
  • Monroe ML; Georgia Emerging Infections Program, Atlanta, Georgia, USA.
  • Kim S; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA.
  • Nunez VT; Emory University School of Medicine, Atlanta, Georgia, USA.
  • McMahon M; Georgia Emerging Infections Program, Atlanta, Georgia, USA.
  • McMullen C; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA.
  • Khanlian SA; Emory University School of Medicine, Atlanta, Georgia, USA.
  • Spina NL; Maryland Department of Health, Baltimore, Maryland, USA.
  • Muse A; Michigan Department of Health and Human Services, Lansing, Michigan, USA.
  • Gaitán MA; Michigan Department of Health and Human Services, Lansing, Michigan, USA.
  • Felsen CB; Minnesota Department of Health, St. Paul, Minnesota, USA.
  • Lung K; New Mexico Department of Health, Albuquerque, New Mexico, USA.
  • Shiltz E; University of New Mexico Health Science Center, Santa Fe, New Mexico, USA.
  • Sutton M; New York State Department of Health, Albany, New York, USA.
  • Thomas A; New York State Department of Health, Albany, New York, USA.
  • Talbot HK; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Schaffner W; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Price A; Ohio Department of Health, Columbus, Ohio, USA.
  • Chatelain R; Ohio Department of Health, Columbus, Ohio, USA.
  • Reed C; Oregon Health Authority, Portland, Oregon, USA.
  • Garg S; Oregon Health Authority, Portland, Oregon, USA.
Open Forum Infect Dis ; 10(1): ofac681, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36686630
From surveillance data of patients hospitalized with laboratory-confirmed influenza in the United States during the 2015-2016 through 2018-2019 seasons, initiation of antiviral treatment increased from 86% to 94%, with increases seen across all age groups. However, 62% started therapy ≥3 days after illness onset, driven by late presentation to care.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos